Riskpilot← Back to searchSign inGet full accessSUPRADENT ApS
APSActiveCVR 28976364Nørre Farimagsgade 33, 1. thManufacture of medical and dental instruments and supplies · NACE 3250Est. 20057 employees
Revenue 2024
DKK 4,4M
+18% vs 2023
EBITDA margin
15.9%
+221% vs 2023
Equity ratio
45.9%
Financial strength
Net profit 2024
DKK 481K
+506% vs 2023
| Revenue | DKK 4,4M | +18% |
| EBITDA | DKK 697K | +221% |
| Net profit | DKK 481K | +506% |
| Total assets | DKK 2,3M | +19% |
| Equity | DKK 1,1M | +82% |
| Employees | 7 | — |
Legal name
SUPRADENT ApS
CVR number
28976364
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
25. august 2005
Share capital
DKK 125.000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er at drive dental laboratorium.
Address
Nørre Farimagsgade 33, 1. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.383 | 3.236 | 3.509 | 3.143 | 4.422 | 5.144 | 4.136 | 3.456 | 3.238 | 3.399 | 3.449 | 3.715 | 4.373 |
| Staff expenses | -2.980 | -3.004 | -3.110 | -3.111 | -3.617 | -4.253 | -4.474 | -3.160 | -2.800 | -3.108 | -3.217 | -3.498 | -3.676 |
| EBITDA | 402 | 232 | 399 | 31 | 805 | 891 | -339 | 295 | 438 | 291 | 232 | 217 | 697 |
| Depreciation & amort. | 163 | -141 | -45 | -31 | -31 | -45 | -91 | -104 | -98 | -89 | -80 | -64 | -57 |
| EBIT | 239 | 90 | 354 | 1 | 774 | 846 | -430 | 191 | 340 | 202 | 153 | 153 | 640 |
| Net financials | -13 | -10 | -4 | -0 | -7 | -27 | -38 | -20 | -9 | -1 | -22 | -40 | -14 |
| Profit before tax | 226 | 80 | 350 | 1 | 768 | 820 | -468 | 172 | 331 | 201 | 131 | 114 | 625 |
| Tax | 59 | 26 | 90 | 3 | 173 | 188 | 6 | -60 | 80 | 50 | 35 | 34 | 144 |
| Net profit | 167 | 54 | 260 | -3 | 595 | 632 | -473 | 232 | 252 | 151 | 96 | 79 | 481 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.221 | 1.228 | 1.281 | 1.069 | 1.966 | 2.541 | 1.736 | 1.663 | 1.732 | 1.869 | 1.961 | 1.959 | 2.331 |
| Equity | 764 | 618 | 879 | 676 | 1.271 | 1.503 | 529 | 761 | 762 | 663 | 509 | 588 | 1.070 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 226 | 0 | 76 | 193 | 193 | 102 | 102 | 102 |
| Short-term debt | 457 | 609 | 403 | 393 | 695 | 805 | 1.194 | 826 | 777 | 1.013 | 1.350 | 1.268 | 1.160 |
| Total debt | 457 | 609 | 403 | 393 | 695 | 1.032 | 1.194 | 902 | 970 | 1.206 | 1.452 | 1.371 | 1.262 |
EBITDA margin
15.9%
This company
15.8%
Market median
+1% vs market
20122024
Equity ratio
45.9%
This company
38.2%
Market median
+20% vs market
20122024
Return on equity
45.0%
This company
18.4%
Market median
+145% vs market
20122024
Net profit margin
11.0%
This company
8.1%
Market median
+36% vs market
20122024
Asset turnover
1.88×
This company
1.12×
Market median
+68% vs market
20122024
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KC Management | Management | 2005 | — | — |
KE Management | Management | 2005 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CKI ApS | Company | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CKI ApS
SUPRADENT ApS Board members of SUPRADENT ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristina Christiansen | Management | 0 companies |
| Kenneth Elemark | Management | 0 companies |